Donepezil for mild cognitive impairment
31 results
1 - 31
Donepezil for mild cognitive impairment 
Donepezil for mild cognitive impairment: Cochrane systematic review
Low-quality evidence: Adding traditional Chinese herbs to donepezil improves cognitive function in adults with mild impairment- Donepezil for vascular cognitive impairment: Cochrane systematic review
- Donepezil for vascular cognitive impairment
- Treatment of a patient with memory disease
- Donepezil for Alzheimer’s disease
- Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta‐analysis
- Donepezil for dementia due to Alzheimer's disease
- Galantamine for Alzheimer’s disease
- Cholinesterase inhibitors for mild cognitive impairment
- AAN guideline for patients with mild cognitive impairment
- Medications ineffective to prevent cognitive decline or dementia
- Dementia treatments minimally effective
- Pharmacological treatment for memory disorder in multiple sclerosis: Cochrane systematic review
- Statins for the treatment of dementia
- Cholinesterase inhibitors cause fewer falls but more syncope in adults with neurocognitive disorders
- Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia
- Continuation and maintenance treatments for depression in older people